# Dr. Manuel Martinez-Maldonado: A Pioneer in Renal Therapeutics and Mentor to a Generation of Minority Physician-Scientists

**Authors:** Jorge R Figueroa-Quintana, Simran Rajput, David J Chow, Estela S Estapé

PMC · DOI: 10.7759/cureus.68776 · 2024-09-06

## TL;DR

Dr. Manuel Martinez-Maldonado was a pioneering nephrologist and mentor who advanced renal research and education.

## Contribution

He developed standard treatments for hypercalcemia and mentored a generation of physician-scientists.

## Key findings

- Furosemide with IV fluid therapy became a standard treatment for hypercalcemia.
- His research on renal physiology and electrolyte metabolism influenced clinical practice.
- He fostered a culture of mentorship and interdisciplinary research in nephrology.

## Abstract

Dr. Manuel Martinez-Maldonado is a distinguished Puerto Rican internist, nephrologist, physician-scientist, mentor, and prolific writer whose leadership in academic and clinical settings has significantly advanced the fields of nephrology, renal physiology and pharmacology, fluids and electrolyte metabolism, calcium metabolism, hypertension research, and medical education. His research on electrolyte imbalances has led to innovative hypercalcemia treatments, notably furosemide with IV fluid therapy. This is an approach that, combined with pharmacotherapy using calcitonin and bisphosphonates, became the standard practice for managing hypercalcemia until specific therapies became available. His nephrology research team and laboratory in the San Juan VA (Veterans Affairs) Medical Center and the Medical School of the University of Puerto Rico were internationally renowned. Throughout his career, he fostered a culture of mentorship while spearheading superb clinical teaching and research initiatives. His transformative tenures at several institutions, including Baylor College of Medicine; the University of Puerto Rico-Medical Sciences Campus; the VA medical centers in Atlanta, Houston, and San Juan; Emory University; Oregon Health Sciences University; Ponce School of Medicine; and the University of Louisville School of Medicine demonstrate his lasting contributions to medical science and education. His interdisciplinary approach, advocacy for kidney and clinical research, and contributions to understanding the renin-angiotensin system and the role of sodium-potassium-activated adenosine triphosphatase in renal concentration mechanisms illustrate his enduring impact on renal physiology and human health.

## Linked entities

- **Diseases:** hypercalcemia (MONDO:0001566)

## Full-text entities

- **Genes:** REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, ATP1B1 (ATPase Na+/K+ transporting subunit beta 1) [NCBI Gene 481] {aka ATP1B}
- **Diseases:** hypercalcemia (MESH:D006934), hypertension (MESH:D006973)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11378457/full.md

---
Source: https://tomesphere.com/paper/PMC11378457